Types of Depression: Diagnoses and Clinical Specifiers
Author: Angela Bogdanova · Published: October 8, 2026 · Editorial Policy
Research cluster: Depression & Depressive Disorders · Written by Artificial Sapiens
Depression is described in several different ways in clinical practice. A type can be a separately recognized depressive disorder, a particular kind of depressive episode, a specifier describing its symptoms, or a pattern describing when episodes occur. These categories answer different questions. Understanding their relationship explains why “major depression,” “dysthymia,” “seasonal depression,” “psychotic depression,” and “atypical depression” can all appear in one discussion without being five equivalent diagnoses.
The two central long-term diagnostic categories for this guide are major depressive disorder (MDD) and persistent depressive disorder (PDD). Clinicians also assess the features, severity, duration, recurrence, and causes of depressive episodes. Bipolar depression, depressive conditions tied to reproductive transitions, and other neighboring diagnoses require their own diagnostic pathways. The central sources for this classification are the National Institute of Mental Health, the DSM-5-TR clinical framework summarized in CANMAT's guideline, and the World Health Organization's ICD-11 framework.
I. What Does “Type of Depression” Mean Clinically?
A diagnosis identifies a defined disorder after assessment of symptoms, duration, functional consequences, history, and relevant exclusions. A major depressive episode is a time-bounded syndrome that can occur within more than one disorder. A specifier provides additional information about the presentation of an episode or its course. A symptom, such as low mood or loss of pleasure, is an individual experience or observation rather than a diagnosis. An informal expression may communicate a lived experience without having formal diagnostic criteria.
For example, someone may receive a diagnosis of major depressive disorder, recurrent, with melancholic features, currently severe. The disorder is MDD. “Recurrent” describes the history of separate episodes. “Melancholic features” identifies a symptom pattern. “Severe” describes the current episode's burden and functional impact. The full formulation is more informative than choosing one label from an internet list of depression types.
The names and groupings also depend on the classification being used. American clinicians commonly work with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), while international reporting and practice use the WHO's International Classification of Diseases, Eleventh Revision (ICD-11). Their definitions overlap substantially, but chapter structure, episode labels, and coding conventions are not identical. The American Psychiatric Association's DSM-5-TR resources and WHO ICD-11 provide the underlying classification systems.
1. A practical classification map
Major depressive disorder and persistent depressive disorder are diagnostic categories. A single or recurrent episode describes the course of depression, and ICD-11 separately organizes single-episode and recurrent depressive disorder diagnoses. Melancholic, atypical, psychotic, anxious-distress, mixed, and catatonic features describe clinically recognized episode characteristics in DSM terminology. Seasonal pattern and peripartum onset locate a characteristic course or timing. A mild, moderate, or severe rating is a severity description. “Smiling depression,” “high-functioning depression,” and “situational depression” are familiar phrases that require translation into the person's actual symptoms and circumstances.
II. Major Depressive Disorder (MDD)
Major depressive disorder is the best-known depressive disorder. Its defining feature is at least one major depressive episode. In the DSM clinical framework, an episode involves a cluster of symptoms persisting during the same period for at least two weeks, representing a change from previous functioning. At least one central symptom is depressed mood or markedly diminished interest or pleasure. Clinicians assess the full symptom constellation, impairment or distress, and whether substances, medical conditions, or a bipolar-spectrum history better explain the presentation. See the NIMH clinical overview and CANMAT diagnostic guidance.
Common episode symptoms include disturbed sleep, appetite or weight change, low energy, diminished concentration, psychomotor slowing or agitation observable by others, excessive guilt or worthlessness, and thoughts about death or suicide. A person does not need every symptom. Low mood may be described as emptiness, numbness, irritability, or persistent loss of enjoyment. In children and adolescents, irritability can be especially prominent. Clinical diagnosis depends on the full pattern rather than a single symptom.
Depression can be profound even when someone remains employed, attends school, or maintains relationships. Observable performance does not directly measure an individual's internal suffering, effort required to function, or safety risk. Conversely, an isolated period of sadness, fatigue, or difficulty concentrating may have many explanations and does not establish MDD.
2. A major depressive episode is not the same as MDD
A major depressive episode is an episode-level description. Major depressive disorder is a disorder-level diagnosis reached after assessment of the episode and its context. This distinction matters because major depressive episodes can occur in bipolar disorders, and some episodes arise in connection with substances or physical illness. A person who has experienced an episode of depression cannot be classified correctly by counting symptoms alone; their longitudinal mood history is indispensable.
3. Single-episode, recurrent, and chronic presentations
An individual may experience one major depressive episode or multiple episodes separated by periods of improvement. A recurrent course does not imply continuous symptoms between episodes. Some depressive episodes last much longer than the two-week minimum; when full or residual symptoms extend over years, clinicians assess persistent depressive disorder and relevant course terminology. ICD-11 recognizes single-episode depressive disorder and recurrent depressive disorder as named categories. DSM-5-TR uses course information within MDD. Both frameworks ask clinicians to describe what has happened over time, not only what is happening today. CANMAT discusses recurrence and chronic presentations.
III. Persistent Depressive Disorder (Dysthymia)
Persistent depressive disorder describes a long-lasting depressive course. Under DSM-5-TR, the central duration threshold is at least two years in adults and at least one year in children and adolescents, with depressed or irritable mood present for much of that period and additional depressive symptoms. Brief fluctuations are possible, but the chronic pattern is essential. The older name dysthymia remains familiar. The NIMH overview describes this extended course, and CANMAT explains how DSM-5-TR groups chronic depressive presentations.
PDD is sometimes introduced as “milder depression that lasts longer.” That description can be misleading. Chronic symptoms can cause major occupational, social, and personal consequences, and the disorder may include periods meeting full criteria for a major depressive episode. DSM-5-TR's PDD category encompasses long-standing lower-intensity symptoms and certain chronic major-depression courses; it is therefore broader than the older narrow use of dysthymia.
4. What is double depression?
“Double depression” is a descriptive clinical phrase historically used when a major depressive episode occurs on top of an established dysthymic or persistent depressive course. It helps explain worsening against a chronically low baseline. It is not a separate DSM-5-TR disorder. A clinical formulation specifies whether full major-episode criteria are currently met, the persistent history, current severity, and relevant modifiers.
A patient who cannot remember a long period of feeling well may have normalized persistent symptoms as part of their personality. This makes a careful time line of mood, sleep, motivation, activity, and functioning particularly useful. Chronicity influences treatment planning and the need for sustained follow-up; it does not mean that meaningful improvement is impossible. CANMAT's adult MDD guidelines address chronic depressive presentations and functioning.
IV. Seasonal Depression and the Seasonal Pattern Specifier
Seasonal affective disorder, usually abbreviated SAD, is a widely used clinical name for depression that follows a recurring seasonal pattern. In the DSM framework, the formal classification is typically major depressive disorder or bipolar disorder with a seasonal pattern specifier, when its requirements are met. A seasonal presentation is therefore a description of timing and recurrence rather than a stand-alone disorder category equivalent to MDD. NIMH's seasonal affective disorder publication explains this distinction and the usual winter pattern.
The most familiar pattern begins in fall or winter and improves in spring or summer, although summer-pattern depression also occurs. Clinicians look for a consistent temporal relationship between episode onset or remission and particular seasons, a recurrent history generally extending across two years, and a predominance of seasonal episodes relative to nonseasonal episodes. A stressful event that happens to occur in winter does not itself prove a seasonal specifier.
Seasonal episodes may involve oversleeping, greater appetite, carbohydrate craving, weight change, fatigue, and social withdrawal, but individual presentations vary. Winter blues and short-lived discomfort with reduced daylight are not automatically depressive episodes. In treatment discussions, light exposure, psychotherapy, medication, circadian patterns, and individual risks may be relevant. Light-therapy efficacy and safety require context: NICE characterizes the evidence for winter depression as uncertain when advising patients who prefer it over standard treatment, while NIMH describes available approaches. A history of mania or hypomania warrants particular caution with activating interventions.
V. Depression With Psychotic Features
Major depression with psychotic features involves a depressive episode accompanied by delusions, hallucinations, or both, in a presentation assessed as part of the depressive illness. Delusions are firmly held beliefs that remain despite persuasive contrary evidence; hallucinations are perceptions occurring without corresponding external stimuli. Psychotic symptoms may express depressive themes such as extreme guilt, imagined punishment, catastrophe, or worthlessness, although they are not always mood-congruent.
Psychotic depression has special clinical significance because diagnostic assessment, immediate risk evaluation, and treatment selection can differ from those for depression without psychosis. Confusion, refusal to eat or drink, inability to care for oneself, severe agitation, or beliefs that place a person in danger may require urgent assessment. NICE NG222 recommends specialist mental health referral and coordinated care; a combination of antidepressant and antipsychotic treatment may be considered, and electroconvulsive therapy is an option for selected severe presentations.
Psychotic features are a clinical specifier, not evidence that the person has schizophrenia. Clinicians distinguish psychotic depression from primary psychotic disorders, bipolar disorder, delirium, substance-related conditions, and medical or neurologic causes by examining symptom timing, course, and associated findings. A sudden onset of psychosis, marked disorganization, or imminent danger requires prompt local emergency or specialist services.
VI. Melancholic Features
The melancholic-features specifier identifies a distinctive depressive presentation centered on profound loss of pleasure or little responsiveness to ordinarily positive events, along with other characteristic findings. These may include marked psychomotor change, early-morning waking, pronounced morning worsening, reduced appetite or weight loss, and excessive or inappropriate guilt. A melancholic presentation can be severe, but its definition is based on a symptom pattern, not solely on a severity score. CANMAT's evidence-based classification discussion describes melancholia among DSM-5-TR episode specifiers.
The term “melancholic depression” is common shorthand. In formal DSM-based language, “MDD with melancholic features” indicates the diagnostic structure. It does not establish a uniquely proven cause such as a specific neurotransmitter imbalance, and research does not support choosing a particular antidepressant solely because melancholic features are present. The CANMAT guidelines identify limited evidence for specifier-specific medication selection outside certain contexts.
VII. Atypical Features
“Atypical depression” is an unfortunate historical label because the symptoms it describes are not necessarily rare. In formal DSM language, “with atypical features” is an episode specifier. Mood reactivity—improvement in mood in response to an actual or potential positive event—is a defining element, together with other features that can include increased appetite or weight gain, hypersomnia, heavy or leaden feelings in the limbs, and longstanding sensitivity to interpersonal rejection that contributes to impairment. CANMAT treats atypical features as a recognized specifier rather than a separate disease.
A person can meet criteria for depression while still laughing at a joke, enjoying a temporary pleasant encounter, or experiencing some relief during a positive event. Mood reactivity does not cancel the broader depressive syndrome. Likewise, atypical features do not necessarily mean a less serious illness. The patient's duration of symptoms, associated features, functional impact, safety, and other diagnoses remain essential to assessment.
Melancholic and atypical features are sometimes described as opposite poles because one emphasizes limited positive mood reactivity and the other includes mood reactivity. Real clinical histories contain variability and overlapping symptoms; clinicians apply formal criteria rather than guessing from one feature such as oversleeping or early awakening.
VIII. Anxious Distress, Mixed Features, and Catatonia
5. Depression with anxious distress
The anxious-distress specifier identifies clinically significant anxiety symptoms within a depressive episode, such as feeling tense, restless, unusually worried, or afraid that something terrible will happen. Anxiety disorders may coexist with depressive disorders, but anxious distress as a specifier does not automatically mean a separate anxiety-disorder diagnosis is present. A complete interview evaluates both possibilities. CANMAT links anxious distress with more difficult depressive courses while cautioning against automatic medication selection on this basis alone.
Symptoms of anxiety and depression often reinforce one another through sleep disruption, worry, avoidance, diminished activity, and loss of functioning. Our separate published article on anxiety and depression occurring together addresses that cross-diagnostic question in depth.
6. Depression with mixed features
A depressive episode “with mixed features” includes certain manic or hypomanic symptoms that fall short of a full manic or hypomanic episode. Such symptoms can include an unusually elevated or expansive mood, increased energy, reduced need for sleep, racing thoughts, or other changes that require careful evaluation. The precise criteria are narrower than everyday descriptions such as feeling agitated, moody, or simultaneously anxious and sad.
The mixed-features specifier is particularly important because the history may reveal bipolar illness or future risk of a manic or hypomanic episode. A clinician should examine past periods of markedly increased energy or activity, decreased need for sleep without fatigue, unusual impulsivity, expansive confidence, pressured speech, and shifts noticed by others. NIMH's bipolar disorder publication explains mood episodes, and CANMAT recommends specialist consultation and careful monitoring in mixed-feature depression.
Treatment choices deserve additional scrutiny when mixed features are present. In particular, medication decisions must reflect the possibility of an underlying bipolar disorder and the risk of activation or treatment-emergent hypomania or mania. “Mixed depression” is not a license to diagnose bipolar disorder from a single symptom, nor is it a reason to ignore a credible history of elevated or irritable high-energy episodes.
7. Depression with catatonic features
Catatonia is a serious psychomotor syndrome that can involve striking reductions or abnormalities in movement and responsiveness, mutism, posturing, rigidity, or, in some presentations, excessive purposeless activity. It can occur with mood disorders and multiple other psychiatric or medical conditions. The presence of catatonic signs requires an appropriate medical assessment because some cases involve dehydration, immobility complications, autonomic instability, or conditions needing rapid treatment.
Catatonia associated with depression calls for specialist or hospital-level judgment rather than an ordinary self-help protocol. CANMAT identifies catatonic features among depressive-episode specifiers and describes specialist treatment considerations. A person who becomes largely unresponsive, cannot eat or drink, or experiences severe changes in behavior should receive urgent medical evaluation.
IX. Peripartum Onset and Other Reproductive Presentations
“With peripartum onset” specifies the timing of a mood episode beginning during pregnancy or shortly after childbirth according to the classification in use. In clinical communication, perinatal depression often describes a broader period spanning pregnancy and the first postpartum year. Because onset windows and practical care pathways are not identical across terms, clinicians record when symptoms began and consider reproductive, sleep, medical, psychosocial, and safety factors. The NIMH depression overview identifies perinatal depression as an important presentation.
Perinatal depression, postpartum depression, postpartum psychosis, premenstrual dysphoric disorder, and mood symptoms during perimenopause have different assessment needs and should not be collapsed into one universal “female depression” category. Premenstrual dysphoric disorder is a separately defined cyclical disorder in DSM classification; postpartum psychosis is a psychiatric emergency that demands urgent specialist assessment. Their dedicated clinical coverage belongs in reproductive and perinatal mental health, while this article identifies where the taxonomy intersects.
X. Other Recognized Depressive Disorders and Clinical Contexts
8. Other specified and unspecified depressive disorders
Formal diagnostic systems include categories for clinically significant depressive presentations that do not meet every criterion for a named major depressive disorder or another defined depressive disorder. In DSM-5-TR, “other specified depressive disorder” can describe a recognized subthreshold pattern while stating the reason full criteria are not met; “unspecified depressive disorder” is used when greater diagnostic specificity is not provided or is unavailable. These labels still call for clinical assessment of severity, impairment, duration, safety, and explanatory context. See the American Psychiatric Association's DSM-5-TR resources.
Subthreshold depressive symptoms merit attention because they may be distressing and impair functioning even when a person does not meet criteria for a major depressive episode. They can arise during recovery, precede a later episode, or reflect a different clinical or contextual problem. A screening questionnaire may identify their presence, but the instrument by itself does not decide which diagnosis fits.
9. Depression induced by substances, medications, or medical conditions
A depressed presentation may be caused or substantially influenced by a substance, medication, or another medical illness. Clinicians consider symptom onset relative to medication changes, substance use or withdrawal, endocrine disease, neurologic conditions, sleep disorders, and other medical findings. This differential diagnosis can alter treatment substantially. The NIMH publication recognizes that medications and medical conditions may produce or worsen depressive symptoms, while the DSM-5-TR fact sheets document separate medical-condition-related diagnostic categories.
A physical illness and a depressive disorder can also coexist. The discovery of a medical diagnosis does not automatically invalidate independently established depressive symptoms, and a history of depression should not cause new physical symptoms to be dismissed. Individual medical evaluation guides testing; there is no single laboratory panel or brain scan that confirms all depressive disorders.
10. Disruptive mood dysregulation disorder in children
Disruptive mood dysregulation disorder (DMDD) is a separate DSM depressive-disorders diagnosis relevant to childhood, characterized by a chronic irritability pattern and severe recurrent temper outbursts under specific age, duration, and setting requirements. It should not be confused with an ordinary depressive episode or assumed from a child being irritable. Pediatric assessment also considers developmental context, trauma, neurodevelopmental conditions, family circumstances, and other causes. The DSM-5-TR resources place childhood mood and related differential categories in a formal clinical framework.
11. Mixed depressive and anxiety disorder in ICD-11
ICD-11 includes a mixed depressive and anxiety disorder category for a specified combination of depressive and anxiety symptoms in which neither individual syndrome reaches the threshold for its corresponding disorder. This differs from having two fully established diagnoses simultaneously and from DSM-5-TR's “with anxious distress” specifier. Classification terminology matters when comparing international studies or medical records. Consult the WHO ICD-11 browser for current wording and coding.
XI. Depression Types That Belong to Other Diagnostic Families
12. Bipolar depression
Bipolar depression refers to depressive episodes occurring within bipolar disorders. The episode may resemble unipolar major depression, and symptoms alone may not reveal a previous episode of mania or hypomania. A careful longitudinal history asks about distinct periods of increased energy or activity, significantly reduced need for sleep, unusually expansive or irritable mood, and consequential changes in behavior. Bipolar I and bipolar II disorder have their own diagnostic criteria and treatment pathways. NIMH outlines the differences.
The distinction has practical consequences. Treatment with antidepressants alone may be inappropriate in some bipolar presentations, and depression with mixed features requires particular attention. A current depressive episode should be evaluated for past mania and hypomania before a treatment plan is finalized. This article maintains the depression-taxonomy overview while the detailed bipolar classifications belong to the bipolar-disorders section of the Hub.
13. Grief, adjustment disorder, and burnout
Grief after loss can include intense sadness, sleep changes, withdrawal, and loss of motivation. Some grieving people also develop a major depressive episode, but the presence of bereavement alone neither proves nor excludes a depressive disorder. Prolonged grief disorder has its own requirements and assessment pathway. Adjustment disorder with depressed mood refers to a particular response to an identifiable stressor and is classified separately from MDD; chronology, breadth of symptoms, severity, impairment, and other criteria matter.
Occupational burnout is recognized in ICD-11 as an occupational phenomenon rather than a depressive disorder. Exhaustion and reduced performance can overlap with depressive symptoms, and the conditions can coexist. Clinicians examine whether the disturbance extends beyond work and whether criteria for a depressive disorder are met. Our classification here preserves separate editorial owners for grief, adjustment reactions, and occupational burnout. Readers interested in an established related pathway can consult the published historical discussion of depressive neurosis and dysthymia.
XII. Popular Names That Are Not Official Diagnoses
14. High-functioning depression and smiling depression
“High-functioning depression” and “smiling depression” describe people who outwardly appear capable, cheerful, sociable, or productive while experiencing significant depressive symptoms. Neither expression is a separately defined DSM-5-TR or ICD-11 depressive disorder, and neither has a standardized diagnostic threshold. A person using either term could have MDD, PDD, subthreshold symptoms, another mental health condition, or difficulties that require a different formulation.
The phrase “high functioning” can obscure what functioning costs: someone may maintain responsibilities through exceptional effort while experiencing significant internal distress, exhaustion, social isolation, or suicidal thinking. It can also overstate what is known about a stranger from their appearance. A clinician assesses subjective experiences, episode duration, impairment, past history, and safety rather than assigning a popular label based on smiling or professional achievement.
15. Situational, reactive, and hidden depression
“Situational depression” and “reactive depression” may describe depressive symptoms associated with an event, but they are not precise replacements for modern diagnostic evaluation. A serious life event can precede MDD, adjustment disorder, ordinary distress, or a mixture of problems; its role does not establish the diagnosis. “Hidden depression” is similarly a conversational expression, not a reliably defined clinical syndrome.
“Endogenous depression,” “neurotic depression,” and “depressive neurosis” appear in historical writing. Modern clinical classifications rely on specific symptom, course, and differential criteria rather than assuming that an external trigger or an internally generated mechanism divides all depression into two biologically distinct diseases. The published history of depressive neurosis explains those older formulations.
16. Depression without sadness
Depression can be experienced primarily as reduced interest, anhedonia, emotional numbness, profound fatigue, or an inability to anticipate pleasure. The presence or absence of the word “sadness” in a person's description is less important than the total syndrome. Conversely, numbness alone cannot establish a depressive disorder. Recognition depends on symptom combination, persistence, change from baseline, functional impact, and clinical differential assessment.
XIII. Mild, Moderate, and Severe Depression Are Severity Descriptions
Severity ratings communicate how extensive and intense depressive symptoms are, how much they interfere with daily life, and whether particular dangerous features are present. A mild presentation may still deserve care; severe depression may involve major inability to function, psychotic symptoms, serious self-neglect, or marked suicide risk. Severity is evaluated together with clinical judgment and contextual factors, not reduced to a rigid single questionnaire number.
NICE's guideline organizes treatment discussions around “less severe” and “more severe” depression for particular clinical decisions, whereas DSM-5-TR and ICD-11 also provide diagnostic severity descriptors. These frameworks have different purposes and should not be treated as interchangeable cutoffs. See NICE's treatment guidance and CANMAT.
A questionnaire score can quantify reported symptoms and help track change, but it cannot distinguish all causes of low mood, detect every bipolar history, diagnose psychotic depression, or replace a clinician's assessment of immediate safety. The U.S. Preventive Services Task Force supports depression screening in adults within systems that provide appropriate diagnostic evaluation, treatment, and follow-up.
XIV. How Clinicians Determine Which Description Fits
The diagnostic process usually begins with an interview about current symptoms, their onset and frequency, sleep and appetite changes, interest or pleasure, concentration, energy, psychomotor changes, distress, and interference with work, school, relationships, and self-care. Clinicians ask whether symptoms occur most days, whether there was a clear change from baseline, and whether previous episodes had the same features. They then build a longitudinal history to distinguish an episodic course from years of persistent symptoms.
A careful evaluation includes questions about manic and hypomanic periods, mixed symptoms, psychotic experiences, suicidal thoughts, self-harm, substance use, current medications, medical conditions, pregnancy or postpartum timing when relevant, traumatic experiences, grief, and major contextual stressors. The aim is to select a clinically meaningful formulation and appropriate care. Depending on the findings, the clinician may arrange a physical examination or targeted laboratory tests, or request specialist consultation. CANMAT and the VA/DoD major depressive disorder guideline address these assessments.
17. Questions that help establish the history
It can be useful to describe when the symptoms began, whether there were symptom-free months, whether a seasonal rhythm has occurred over several years, whether there have been previous periods of unusually high energy with little sleep, whether medication or substance changes preceded a decline, and how functioning has changed. Notes from trusted people may add useful observations with consent, especially when a person has difficulty remembering a hypomanic episode or identifying psychotic symptoms.
A person does not need to determine the right specifier before seeking care. Describing experiences in ordinary language is enough to begin. A clinician can explain which findings support the diagnosis, which alternative explanations remain possible, and whether reassessment is needed as new history becomes available.
XV. How Depression Type and Features Affect Treatment
Most established approaches to unipolar depressive disorders include evidence-based psychotherapy, antidepressant medication when appropriate, collaborative monitoring, and practical support adapted to severity, access, prior response, comorbidity, and patient preferences. Treatments are selected for the person and the overall clinical presentation, not mechanically for a marketing label. NICE NG222, the VA/DoD guideline, and CANMAT provide detailed clinical recommendations.
18. Major depressive disorder and persistent depressive disorder
For a new episode of less severe depression, guided self-help and structured psychotherapies may be appropriate; medication can be considered according to the individual's needs and informed preferences. More severe presentations may warrant medication, psychotherapy, or their combination, as well as closer monitoring. Persistent depressive disorder frequently requires a sustained plan for functioning, symptom relief, treatment adherence, and long-term evaluation. No single intervention guarantees remission, and the choice should account for past benefits, adverse effects, accessibility, and what the person values.
19. Psychotic, catatonic, and very severe depression
Psychotic depression should receive specialist mental health assessment because treatment may involve an antidepressant and antipsychotic together, and certain severe or urgent situations may call for electroconvulsive therapy. Catatonic features likewise require a specialist medical response. ECT is a medically supervised procedure performed under anesthesia and carries meaningful consent, cognitive, and medical considerations. The decision balances potential benefit against risk and urgency. NICE recommendations describe referral and ECT indications.
20. Seasonal presentations
Treatment discussions for seasonal-pattern depression may include structured psychotherapy, antidepressants, scheduled light therapy, and attention to sleep-wake rhythms. Evidence and suitability differ across interventions, and a clinician should ask about eye conditions, relevant medications, insomnia, agitation, and any bipolar-spectrum symptoms before recommending bright-light protocols. Self-treatment with an uncontrolled high-intensity device is especially unwise when there are manic symptoms or an uncertain diagnosis. The NIMH seasonal depression resource and NICE describe clinical considerations.
21. Treatment resistance and advanced interventions
Treatment-resistant depression is a description of inadequate response after appropriately selected and delivered treatment trials, not another depressive disorder with its own independent diagnostic identity. Before describing a case as resistant, clinicians reassess diagnosis, previous treatment adequacy, adherence and tolerability, physical or substance-related contributors, bipolar symptoms, social stressors, and other coexisting conditions. Depending on the situation, care may involve medication optimization, structured psychotherapy, augmentation, electroconvulsive therapy, repetitive transcranial magnetic stimulation, or specialist use of ketamine- or esketamine-based interventions, subject to local approvals and safety systems.
The evidence, regulatory requirements, access, adverse effects, and contraindications differ substantially among ECT, TMS, intravenous ketamine, and intranasal esketamine. They should not be grouped as interchangeable “stronger antidepressants.” CANMAT, NICE, and current specialist guidance support individualized evaluation, with particular attention to monitoring and informed consent. Treatment algorithms for children and adolescents require age-specific evidence and specialist consideration.
22. Medication safety and withdrawal
Antidepressants can provide meaningful benefit, but a treatment plan should include expected effects, adverse effects, interactions, monitoring, and what to do if symptoms worsen. Early agitation, new suicidal thoughts, emerging mania or hypomania, and abrupt behavioral changes warrant timely clinical attention. Starting or stopping antidepressants without a clinician's plan can create avoidable problems, including discontinuation symptoms. Tapering decisions depend on the particular medicine, dose, duration, prior symptoms, and clinical needs. NICE provides detailed recommendations on prescribing, review, and withdrawal.
XVI. Remission, Relapse, Recurrence, and Recovery
Improvement means symptoms or functioning have become better, while remission describes a state in which depressive symptoms have reduced to a level below the defined threshold, depending on the clinical or research definition used. Recovery implies a more sustained and meaningful improvement over time. Relapse generally refers to a return of a depressive episode before a sustained period of recovery has been established. Recurrence refers to a new episode after a period of recovery. These terms describe the course of illness; they do not create additional types of depression.
Residual symptoms, prior episodes, prolonged duration, ongoing stressors, physical illness, and other clinical factors can influence the risk of future episodes. Long-term follow-up may focus on early warning signs, continuing treatment when indicated, sleep and daily structure, behavioral activation, social support, and planning for setbacks. Recurrent depression can improve substantially, while prevention of another episode may remain a separate treatment goal. NICE and CANMAT provide relapse-prevention frameworks.
XVII. When to Seek Evaluation or Urgent Help
A professional evaluation is appropriate when low mood, loss of pleasure, fatigue, reduced functioning, or other depressive symptoms persist, return, or interfere with daily life. A history of repeated winter episodes, years of ongoing low mood, new manic-like symptoms, unexplained behavioral change, or concerning reactions to medication provides additional reason to seek clinical assessment. Care can begin with a primary care clinician or qualified mental health professional, with specialist referral when needed.
Immediate help is necessary when someone has an imminent intention to harm themselves or others, cannot maintain basic safety, develops acute psychosis, shows severe confusion, or becomes unable to eat, drink, or care for essential needs. Contact local emergency services or urgent psychiatric services; in the United States, 988 provides suicide and crisis support. A classification article cannot replace a direct safety assessment. If an immediate danger is present, seek in-person emergency help now.
XVIII. Frequently Asked Questions
23. How many types of depression are there?
There is no single scientifically correct number across every classification. Major depressive disorder and persistent depressive disorder are major diagnostic categories; clinicians also recognize other depressive disorders, symptom patterns, severity grades, and course specifiers. Counting each specifier as a separate disease produces an inflated and misleading answer.
24. Is seasonal affective disorder a separate diagnosis?
SAD is a common name for a seasonal depression pattern. In DSM-based practice, that pattern is expressed through a seasonal-pattern specifier attached to the underlying mood disorder where criteria are met. A seasonal course can occur in unipolar or bipolar illness, so the full history still matters.
25. Is dysthymia different from persistent depressive disorder?
Dysthymia is the older and still familiar term. Persistent depressive disorder is the DSM-5-TR diagnostic term covering a broader set of chronic depressive presentations. A long-lasting major depressive episode may also fall within this framework, so PDD does not always mean only minor symptoms.
26. Can depression be both atypical and severe?
Yes. “Atypical features” identifies a characteristic symptom pattern, while severity describes the overall intensity and impairment. People with an atypical-features presentation can experience considerable distress, significant disability, and serious risk.
27. Is melancholic depression the same as severe depression?
No. Melancholic features describe a specific cluster of depressive symptoms; severity is a separate judgment. Melancholic features can occur in severe episodes, but the two terms answer different questions.
28. Can you have psychotic depression without schizophrenia?
Yes. Psychotic features may occur in a depressive episode and require their own differential diagnosis. A person with psychotic depression is not automatically diagnosed with schizophrenia. These symptoms call for specialist assessment, particularly if they are new, escalating, or associated with danger.
29. Is smiling depression a real medical diagnosis?
The experiences described by “smiling depression” can be very real. The phrase itself is informal and has no distinct DSM-5-TR or ICD-11 diagnostic criteria. A clinician evaluates the underlying symptoms and clinical history.
30. Is bipolar depression just another form of major depressive disorder?
No. A depressive episode within bipolar illness belongs to a different diagnostic disorder, defined by its longitudinal history and manic or hypomanic episodes. This distinction can alter medication and monitoring decisions, making careful history-taking essential.
31. Can a depression questionnaire tell me which type I have?
No. Symptom questionnaires can flag possible depression or measure change, but they cannot establish the precise diagnosis or specifier. A clinical interview and differential assessment are necessary, especially when bipolar symptoms, psychosis, long-standing symptoms, or medical causes may be involved.
32. Do different specifiers always require different medications?
No. Most depressive specifiers have limited value for predicting a uniquely preferred medication. Some presentations, especially psychotic depression and seasonal-pattern depression, may affect treatment planning in distinctive ways. Overall severity, safety, patient preferences, past response, medical conditions, and potential bipolar disorder usually matter more than an isolated descriptive label.
33. Can the diagnosis change over time?
Yes. A longitudinal diagnosis can be refined when an earlier episode is followed by recurrence, previously undisclosed hypomanic symptoms become apparent, persistent duration criteria are met, or another medical or psychiatric explanation emerges. Reassessment is a normal part of responsible clinical care.
XIX. Conclusion
The clearest way to understand the types of depression is to identify the level of classification being discussed. Major depressive disorder and persistent depressive disorder describe depressive disorders; individual depressive episodes have features and severity; seasonal patterns and recurrence describe the course over time; and everyday expressions such as “high-functioning” or “smiling” depression describe experiences in nonstandard language. A careful assessment brings these levels together, rules out important alternatives, and connects the individual clinical presentation to appropriate care.
Related Articles
Anxiety and Depression: Why They Commonly Co-Occur — Understand comorbidity and shared vulnerabilities while preserving two distinct diagnostic pathways.
GAD vs Depression: Worry, Mood, Energy, and Comorbidity — Compare generalized anxiety symptoms with a depressive syndrome.
Depressive Neurosis: Historical Meaning, Dysthymia, and Modern Depressive Disorders — Clarify historical terminology and its relationship to PDD.
Childhood Trauma and Depression: Risk, Mechanisms, and Treatment — Explore adversity as a risk pathway rather than a diagnostic subtype.
OCD vs Depression: What Is the Difference? Rumination, Intrusive Thoughts, Guilt, and Compulsions — Distinguish overlapping symptoms in another clinical territory.
References
American Psychiatric Association. (2022; updates through 2025). DSM-5-TR fact sheets and diagnostic resources. Official American Psychiatric Association resource.
Canadian Network for Mood and Anxiety Treatments (CANMAT). (2024). CANMAT 2023 update on clinical guidelines for management of major depressive disorder in adults. The Canadian Journal of Psychiatry, 69(9), 641–687. https://doi.org/10.1177/07067437241245384.
National Institute for Health and Care Excellence (NICE). (2022). Depression in adults: Treatment and management (NG222). Official recommendations.
National Institute of Mental Health (NIMH). (n.d.). Bipolar disorder. Official NIMH publication.
National Institute of Mental Health (NIMH). (n.d.). Depression. Official NIMH publication.
National Institute of Mental Health (NIMH). (n.d.). Seasonal affective disorder. Official NIMH publication.
U.S. Department of Veterans Affairs & U.S. Department of Defense (VA/DoD). (2022). VA/DoD clinical practice guideline for the management of major depressive disorder. Official guideline.
U.S. Preventive Services Task Force (USPSTF). (2023). Depression and suicide risk in adults: Screening. Recommendation statement.
World Health Organization (WHO). (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioral and neurodevelopmental disorders. Official ICD-11 classification.